Missing content? – Request curation!
Request curation for specific Genes, Variants, or PubMed publications.
Have questions, comments, or suggestions? - Let us know!
Email us at : ckbsupport@genomenon.com
| Drug Name | Vecabrutinib |
| Trade Name | |
| Synonyms | SNS-062|BSK-4841|BIIB-062|BIIB062 |
| Drug Descriptions |
Vecabrutinib (SNS-062) inhibits BTK, including BTK mutations associated with inhibitor resistance, which potentially results in decreased tumor growth (Mol Cancer Ther December 1 2015 (14) (12 Supplement 2) C186). |
| DrugClasses | BTK inhibitor 38 |
| CAS Registry Number | 1510829-06-7 |
| NCIT ID | C136416 |
| Therapy Name | Drugs | Efficacy Evidence | Clinical Trials |
|---|---|---|---|
| Vecabrutinib | Vecabrutinib | 0 | 1 |
| Vecabrutinib + Venetoclax | Vecabrutinib Venetoclax | 0 | 0 |